Tenaya Therapeutics (TNYA) Earnings Date, Estimates & Call Transcripts $1.81 -0.05 (-2.69%) Closing price 10/17/2025 04:00 PM EasternExtended Trading$1.83 +0.02 (+1.05%) As of 10/17/2025 08:00 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Tenaya Therapeutics Earnings Summary Tenaya Therapeutics posted Q2 2025 earnings on August 6, 2025, reporting an EPS of -$0.14, which topped analysts' consensus estimates of -$0.20 by $0.06. With a trailing EPS of -$0.96, Tenaya Therapeutics' earnings are expected to grow next year, from ($1.35) to ($1.26) per share. Upcoming Q3 Earnings DateNov. 5Before Market OpensEstimatedConsensus EPS (Aug. 6) -$0.20 Actual EPS (Aug. 6) -$0.14 Beat By $0.06 Q2 2025 Earnings ResourcesQ2 2025 Earnings Report Press Release (8-K) Quarterly Report (10-Q)TNYA Upcoming EarningsTenaya Therapeutics' Q3 2025 earnings is scheduled for Wednesday, November 5, 2025, with a conference call scheduled on Thursday, November 6, 2025 at 4:00 PM ET. Check back for transcripts, audio, and key financial metrics as they become available.Powered by Get Tenaya Therapeutics Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Tenaya Therapeutics and other key companies, straight to your inbox. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Charts & View Estimated and Actual Earnings DataTNYA Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter. Tenaya Therapeutics Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20254-$0.16-$0.14-$0.15Q2 20254-$0.24-$0.16-$0.18Q3 20254-$0.24-$0.15-$0.18Q4 20254-$0.24-$0.16-$0.19 FY 2025 16 -$0.88 -$0.61 -$0.70 Q1 20261-$0.18-$0.18-$0.18Q2 20261-$0.19-$0.19-$0.19Q3 20261-$0.18-$0.18-$0.18Q4 20261-$0.18-$0.18-$0.18 Tenaya Therapeutics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame Start Date End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 11/5/2025(Estimated)--------8/6/2025Q2 2025-$0.20-$0.14+$0.06-$0.14--5/7/2025Q1 2025-$0.18-$0.24 -$0.06-$0.24--3/17/2025Q4 2024-$0.32-$0.28+$0.04-$0.28--11/6/2024--$0.37-$0.30+$0.07-$0.30--8/8/2024--$0.40-$0.34+$0.06-$0.34--5/14/2024Q1 2024-$0.43-$0.40+$0.03-$0.40--3/18/2024Q4 2023-$0.45-$0.40+$0.05-$0.40--11/8/2023Q3 2023-$0.47-$0.39+$0.08-$0.39-- Tenaya Therapeutics Earnings - Frequently Asked Questions When is Tenaya Therapeutics' earnings date? Tenaya Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, November 5th, 2025 based off last year's report dates. Learn more on TNYA's earnings history. Did Tenaya Therapeutics beat their earnings estimates last quarter? In the previous quarter, Tenaya Therapeutics (NASDAQ:TNYA) reported ($0.14) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.20) by $0.06. Learn more on analysts' earnings estimate vs. TNYA's actual earnings. How much profit does Tenaya Therapeutics generate each year? Tenaya Therapeutics (NASDAQ:TNYA) has a recorded net income of -$111.13 million. TNYA has generated -$0.96 earnings per share over the last four quarters. What is Tenaya Therapeutics' EPS forecast for next year? Tenaya Therapeutics' earnings are expected to grow from ($1.35) per share to ($1.26) per share in the next year. More Earnings Resources from MarketBeat Related Companies Xeris Biopharma Earnings Nuvation Bio Earnings atai Life Sciences Earnings Amylyx Pharmaceuticals Earnings Maze Therapeutics Earnings Immunome Earnings WAVE Life Sciences Earnings Tourmaline Bio Earnings Immatics Earnings Enliven Therapeutics Earnings Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Goldman Sachs Earnings Tell: Markets Seem OkayWhy Congress Is Buying Intuitive Surgical Ahead of Earnings3 Reasons to Buy Sprouts Farmers Market Ahead of EarningsTesla Earnings Loom: Bulls Eye $600, Bears Warn of $300Spotify Could Surge Higher—Here’s the Hidden Earnings SignalBerkshire-Backed Lennar Slides After Weak Q3 EarningsWall Street Eyes +30% Upside in Synopsys After Huge Earnings Fall This page (NASDAQ:TNYA) was last updated on 10/18/2025 by MarketBeat.com Staff From Our PartnersREVEALED: Something Big Happening Behind White House DoorsWhat I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredBuy alert: Move $1,000 before Tesla’s Optimus launchElon's $1,000,000,000,000 payday Elon Musk just made his biggest insider purchase of Tesla stock ever. He's...Altimetry | SponsoredMelt-up warning Porter Stansberry says this bull market is past the “safe zone” and racing toward an event horizon — and in hi...Porter & Company | SponsoredTrump’s “Smart Dollar” just went mainstream"I Made Millions in the Tech Boom. Here's Where I'd Put My Money Today" This man has called some of the big...Stansberry Research | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredWhy More Investors Are Using Family Trusts to Protect Their WealthFor many investors, a family trust can be an essential tool for protecting assets, avoiding probate, and ensur...SmartAsset | SponsoredBuy UBER immediatelyBULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tenaya Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Tenaya Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.